Effectiveness and Tolerability of Vildagliptin and the Single Pill Combination of Vildagliptin and Metformin in “Real-World” Management of Type 2 Diabetes Mellitus: The G-FORCE Study

INTRODUCTION: Randomized clinical trials showed that vildagliptin is well tolerated and leads to clinically meaningful decreases in glycated hemoglobin (HbA1c) and fasting plasma glucose (FPG) both in monotherapy and as add-on therapy in inadequately controlled type 2 diabetes mellitus (T2DM) patien...

詳細記述

保存先:
書誌詳細
出版年:Diabetes Ther
主要な著者: Van Gaal, Luc, Hermans, Michel P., Daci, Evis, Denhaerynck, Kris, De Meester, Lut, MacDonald, Karen, Abraham, Ivo, Vancayzeele, Stefaan, Maris, Michael
フォーマット: Artigo
言語:Inglês
出版事項: Springer Healthcare 2019
主題:
Original Research
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531546/
https://ncbi.nlm.nih.gov/pubmed/30919316
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13300-019-0601-y
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料